Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

PURPOSE: To determine the frequency and prognostic association of molecular markers by anatomic tumor site in patients with stage III colon carcinomas. EXPERIMENTAL DESIGN: In a randomized trial of adjuvant FOLFOX + cetuximab, BRAF(V600E) and KRAS (exon 2) mutations and DNA mismatch repair (MMR) pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Sinicrope, Frank A., Mahoney, Michelle R., Yoon, Harry H., Smyrk, Thomas C., Thibodeau, Stephen N., Goldberg, Richard M., Nelson, Garth D., Sargent, Daniel J., Alberts, Steven R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668228/
https://ncbi.nlm.nih.gov/pubmed/26187617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0527
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados